ZZ Biotech LLC is a San Diego biotech developing 3K3A-APC, an engineered variant of human activated protein C for wound healing.
Founded in 2006 and headquartered in San Diego, US, ZZ Biotech LLC develops 3K3A-APC, a genetically engineered variant of human activated protein C intended for wound healing. Its licensing agreements with Dermatherix, Pty Ltd support clinical development and commercialization. Revenue is expected from licensing fees and possible royalties on sales. Joseph Romano and Kent Pryor are the current CEOs. The company has completed 2 deals; the most recent, on January 1, 2015, raised USD 6.9 mn, the total raised to date.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in